Adverse effects of drugs commonly used in the treatment of urinary tract infection. A report from the Australian Drug Evaluation Committee.
D000667:Ampicillin / Q000009:adverse effects; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects*; D001315:Australia; D002701:Chloramphenicol / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000453:epidemiology; D006801:Humans; D008709:Methenamine / Q000009:adverse effects; D009268:Nalidixic Acid / Q000009:adverse effects; D009582:Nitrofurantoin / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects; D014295:Trimethoprim / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D013449:Sulfonamides; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D014295:Trimethoprim; D013752:Tetracycline; D008709:Methenamine; D013420:Sulfamethoxazole